Skip to main content

Screening Clinical Trials for Colorectal Cancer

Review the colorectal cancer screening clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-22 of 22

The Vanguard Study: Testing a New Way to Screen for Cancer
Status: Active
Location: 27 locations
Colonoscopy versus Stool-Based Testing for Colorectal Cancer Screening in Older Patients with a History of Colon Polyps, The COOP Trial
Status: Active
Location: 14 locations
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
Status: Active
Location: 13 locations
LCAM for Hereditary Cancer Screening in Patients with Cancer, IMAGINE Study
Status: Active
Location: 5 locations
Remotely Delivered, Digital Health Intervention to Improve Colorectal Cancer Screening in Racially Diverse Patients of a Community Health Center
Status: Active
Location: 2 locations
Patient Navigation Services for the Improvement of Cancer Screening among Underserved Neighborhoods in New York City, NYC CONNECT Trial
Status: Active
Location: 2 locations
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
A Proactive Screening Intervention for Increasing Colorectal Cancer Screening among Federally Qualified Health Centers in Brooklyn
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Impact of Protect Your Colon™ on CRC Screening
Status: Active
Location: Cedars Sinai Medical Center, Los Angeles, California
Blood Test (Guardant SHIELD) for Screening of Colorectal Cancer in Underserved Patients
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A Mailed Fecal Immunochemical Test Kit for the Improvement of Colorectal Cancer Screening in Southern California Community Health Centers, CRC-HUB-SPOKE Trial
Status: Active
Location: UC San Diego Moores Cancer Center, La Jolla, California
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Status: Active
Location: Mayo Clinic in Arizona, Scottsdale, Arizona
Genetic Cancer Screening Program for Identifying Women at High Risk for Breast and Colorectal Cancer in Underserved Areas
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Strategies to Promote Colorectal Cancer and Hepatitis C Virus Screening Uptake among Adults that are 45-75 Years Old
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
A Multi-Level Intervention for Improving Screening Rates of Breast, Cervical and Colorectal Cancer in Women in Low-Income Communities
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Random versus Limited Biopsies for the Detection of Precancerous Changes in the Colon among Patients with Inflammatory Bowel Disease, The URBI Study
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients with Abnormal Fecal Immunochemical Test Results, PROACT Trial
Status: Approved
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Family Communications after Genetic Testing
Status: Approved
Location: Location information is not yet available.
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 718 locations
Fitting Non-Invasive Tests in Lynch Syndrome Surveillance: A Prospective Clinical Study
Status: Active
Location: 3 locations
Evaluation of Circulating Tumor DNA for Predicting the Likelihood of Organ Preservation or Pathologic Complete Response after Neoadjuvant Therapy for Patients with Rectal Cancer
Status: Temporarily Closed to Accrual
Location: 2 locations